The Journalist to Journalist Lung Health Media Training is an
all-expenses-paid, six day fellowship for health journalists of the
National Press Foundation and the International Union Against
Tuberculosis and Lung Disease. This 6th annual program is a three-day
intensive training followed by full access to the 45th Union World
Conference on Lung Health—the premier international gathering of lung
health researchers and others.
The training is designed for working journalists who want to increase
their knowledge and skill at developing stories on lung health and
related issues, including tuberculosis; TB/HIV; asthma, COPD, diabetes
and tobacco control. Journalists hear presentations from world-class
experts on these diseases, the extent and impact of the problems they
present (including social, political and economic impacts) and new
research, solutions and innovations in the pipeline. The sessions also
include practical training in turning scientific information into
effective web, print and broadcast stories.
Fellows attend the Union World Conference on Lung Health immediately
following the Media Training (October 27 – 29). This year’s Conference,
continuing through November 1, focuses on “Community-Driven Solutions
for the Next Generation.” The J2J Media Training gives fellows extra
tools and sources to get stories from the Conference.
Applications are sought from journalists working in any medium. Special
though not exclusive attention will be given to applications from
journalists in low- and middle-income countries, along with China,
India, Russia and South Africa. Conference registration, round-trip air
or train travel, hotel accommodation and per diem expenses are included
in the fellowship for chosen fellows.
All J2J sessions will be in English, so proficient spoken and written English are essential. All applicants must be working journalists with at least three years experience covering health issues.
The deadline for applications is 5 PM EST July 18, 2014. Only online applications are accepted.
This program is sponsored by The Lilly MDR-TB Partnership and The
International Union Against Tuberculosis and Lung Disease. Additional
funding provided by Aeras and the TB Alliance.
